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Summary
In  t h i s  t hes i s  va r i ous  pha rmaco log i ca l  i nves t i ga t i ons  pe r fo rmed  w i th
N-0437 are descr ibed.
Chapter  I  ' is  an in t roduct ion to the exper imenta l  chapters of  th is
thes i s .  I t  dea l s  w i t h  t he  ro le  o f  dopamine  i n  t he  b ra in ,  t he  d i seases
in  wh i ch  dopamine  i s  ' i nvo l ved ,  c l ass  i f i ca t i ons  o f  t he  dopamine
receptor  and ' i t  prov ides a rev iew of  the most  se lect ive dopamine
agon i s t s  and  an tagon i s t s .
Chapter  I I  conta ins a shor t  desc-r ip t ion of  the test  models wh' ich have
been used ' in  the exper imenta l  chapters I I I  t / rn  IX.  In  the ' la t ter
chapters these test  models are therefore only br ie f ly  ment ioned.  Th ' is
chap te r  a l so  con ta ins  t he  mos t  recen t  v i ews  on  the ' i nvo l vemen t  o f  D - l
and D-2 receptors in the pharmacological test systems. Moreover the
syn thes i s  o f  N -0437  i s  desc r i bed .
Chapter  I I I  is  a s tudy,  conta in ing a compar ison between N-0437 and two
analogues.  N-0434 and N-0734.  The test  models used are main ly  in  v ivo
tes t  mode ls  f o r  po tency  and  se lec t i v i t y .  Behav iou ra l  as  we l l  as
b iochemica l  s tud ies  a re  desc r i bed .  The  mos t  ' i n te res t ' i ng  resu l t s  o f
t h i s  chap te r  a re  t he  h igh  o ra l  ac t i v ' i t y  and  the  l ong  du ra t i on  o f
act ion of  N-0437.
Chap te r  IV  dea l s  w i t h  t he  i n  v i t r o  ac t i v i t y  o f  t r i t i um- labe l l ed  N -
0437.  3H-t r t -O+:U appeared a ' lso in  v i t ro to be a very potent  dopamine
agon i s t ,  wh ' i ch  was  se lec t i ve  f o r  D -?  recep to rs .  Dopamine  agon i s t s  and
an tagon i s t s  w i t h  D -2  ac t ' i v i t y  a re  po ten t  d i sp lace rs ,  wh i l s t  d rugs
be long ing  to  va r i ous  o the r  pha r rnaco log i ca l  c l asses  appea r  t o  be  ve ry
D O O r  O n e S .
Chap te r  V  i s  an  i n  v i t r o  s tudy  on  the  e f f ec t s  o f  chemica l  l es ions  and
the in f luence of  metal  ions and GTP on the b inding of  3H- l t -O+:Z to D-Z
receptors.  From the les ion exper iments i t  became c lear  that  3t t - l t -O+:Z
preferent ia l ly  b inds to postsynapt ic  dopamine receptors,  GTP and Na+
are  ab le  t o  dec rease  the  spec i f i c  b ind ing  o f  3H- | ! -O+ :Z  wh i l e  Hg* *
c o m p l e t e l y  n u l l i f i e d  t h e  b i n d i n g .
Chapter  VI  is  a s tudy per formed in col  laborat ion wi th other
l abo ra to r i es .  I t  dea l s  abou t  t he  po tency  and  se lec t i v i t y  o f  r acemic  N -
0437 for  dopamine receptors,  N-0437 was tested for  a possib le
discr iminat ion between pre-  and postsynapt ic  dopamine receptors in
v i vo  as  we l l  as  i n  v i t r o ,  and  i n  add i t i on  f o r  poss ib le  se ro tone rg i c
act iv i ty  in  v jvo.  I t  appeared that  racemic N-0437 does not  d iscr imi-
nate between the pre-  and postsynapt ic  receptors and in addi t jon
showed  no  se ro tone rg i c  ac t ' i v i t y  i n  v i vo .  I n  t h i s  s tudy  we  a l so  t es ted
the in  v i t ro af f in i ty  of  racemic N-0437 for  var ious non-dopaminergic
receptors.  I t  appeared that  N-0437 was about  280 t imes more se ' lect ive
for  D-? receptors than for  o2*adrenergic  receptors.  For  other  k ' inds of
receptors the se. lect iv i ty  rat io  was many more t imes b i99er .
Chapter  VI I  descr ibes an in  v i t ro autoradiograph' ic  s tudy wi th rH-N-
0437.  This work was per formed in the research laboratory of  Sandoz in
Base l .  Because  o f  t he  l ow  non -spec i f i c  b ind ing  o f  3H-N-0437 ,  t h i s
compound appears to be an excel lent  radio l  igand to v isua' l ize the D-2
recep to rs  i n  t he  b ra in .  The  pha rmaco log i ca l  p ro f i  l e  and  sa tu rab i  l i t y
obta ined wi th autoradiography were in  very good agreement  wi th the in
v i t r o  rad io l i gand  b ind ing  s tud ies  desc r i bed  i n  chap te r  IV .
Chap te r  V I I I  Th i s  chap te r  dea ' l s  w i t h  ce r ta in  mo1ecu la r  p rope r t i es  o f
the DA receptor .  I t  has been descr ibed jn l i terature that  dopamine
antagonists  are ab ' le  to protect  dopamine receptors against  N-
ethoxycarbony' l -2-ethoxy-1,2-d ' ihydroquinoi ine (EEDQ) induced receptor
inact ivat ion.  I t  has a lso been repor ted that  dopamine agonists  and
an tagon ' i s t s  b ind  to  d i f f e ren t  b ind ' i ng  s i t es .  Because  o f  t he  se lec t i v j -
ty  of  N-0437,  th is  compound was tested for  i ts  poss ' ib ' le  protect ing
capaci ty .  In  contrast  to  dopamine antagonists ,  N-0437 was not  able to
protect  the dopamine D-2 receptor  against  EEDQ induced inact ivat ion,
Chapter  IX In the la t ter  s tages of  th is  research pro ject  racem' ic  N-
0437 was resolved into the (+)  and ( - )  enant iomers.  These opt ica l
ant ipodes were examined in test  models for  pre-  and postsynapt ic
dopaminergic  act ' iv i ty .  I t  appeared that  the (+)  enant iomer a is  vsry
select ive presynapt ic  agonist  and a postsynapt ic  antagonist ,  whi le  the
(- )  enant iomer is  a fu l l  agon' is t  and labels both pre-  and postsynapt ic
receptors.These propert ies are of  importance for  therapeut ic
app l i ca t i on .
From the above studies i t  can be concluded that  N-0437 is  a very
potent  and select ive dopamine D-2 receptor  agonist .  Racemic N-0437 is
capab' le  of  s t imulat ' ing both pre-  and postsynapt ic  receptors.  The (+)
enant iomel i  s  a par t ia l  dopamine agon' is t .  whereas the ( - )  enant iomer
i s  a  f u11  agon i s t .  Because  o f  i t s  po tency  and  se lec t i v ' i t y ,  h i gh  o ra l
act iv i ty  and long durat ion of  act ' ion,  th is  compound is  a very
promis ing candidate for  therapeut ic  use.  The (+)  enant iomer could have
an appl icat ion for  the t reatment  of  schizophrenia as i t  s t imulates in
very low concentrat ions presynapt ic  dopamine receptors.  The ( - )
enant iomer is ,  because of  i ts  potency on postsynapt ic  receptors,  is  a
ve ry  p rom is  i ng  d rug  fo r  Pa rk inson ' s  d i sease .
